Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) causes respiratory infection in humans, with symptom severity that ranges from asymptomatic to severe pneumonia. Known risk factors for severe MERS include male sex, older age, and the presence of various comorbidities. MERS-CoV gains entry into cells by binding its receptor, dipeptidyl peptidase 4 (DPP4), on the surface of airway epithelia. We hypothesized that expression of this receptor might be an additional determinant of outcomes in different individuals during MERS-CoV infection. To learn more about the role of DPP4 in facilitating MERS-CoV infection and spread, we used ELISA and immunofluorescent staining to characterize DPP4 expression in well-differentiated primary human airway epithelia (HAE). We noted wide inter-individual variation in DPP4 abundance, varying by as much as 1000-fold between HAE donors. This variability appears to influence multiple aspects of MERS-CoV infection and pathogenesis, with greater DPP4 abundance correlating with early, robust virus replication and increased cell sloughing. We also observed increased induction of interferon and some interferon-stimulated genes in response to MERS-CoV infection in epithelia with the greatest DPP4 abundance. Overall, our results indicate that inter-individual differences in DPP4 abundance are one host factor contributing to MERS-CoV replication and host defense responses, and highlight how HAE may serve as a useful model for identifying risk factors associated with heightened susceptibility to serious respiratory pathogens.

Highlights

  • In the past two decades, three highly pathogenic human coronaviruses have entered the world stage

  • Using primary airway epithelia from human donors as a model, we found that dipeptidyl peptidase 4 (DPP4) abundance correlated positively with infection and viral replication, and appeared to influence pathogenesis as assessed by cell sloughing/disruption of the epithelium

  • We detected a relationship between DPP4 abundance and progression of the host innate immune response, with high-DPP4 airway epithelial donors exhibiting relatively greater induction of several antiviral genes in response to MERS-CoV infection

Read more

Summary

Introduction

In the past two decades, three highly pathogenic human coronaviruses have entered the world stage. The first, severe acute respiratory syndrome coronavirus (SARS-CoV), caused an epidemic in 29 countries in 2003 that resulted in more than 8,000 cases and nearly 800 deaths (World Health Organization, WHO). Middle East Respiratory Syndrome-CoV (MERS-CoV) is a novel β-coronavirus first isolated in Saudi Arabia in June of 2012 [1]. MERS cases occurred in 27 countries and caused 858 deaths in 2,494 confirmed cases (World Health Organization, WHO). Unlike the short-lived SARS epidemic, MERS-CoV continues to circulate in the Arabian Peninsula (World Health Organization, WHO), DPP4 Variation in Airway Epithelia probably because of continuous zoonotic transmission from local dromedary camels to humans [2]. The emergence of the novel coronavirus SARS-CoV-2 has led to the COVID-19 pandemic, which has sickened millions and continues to cause significant economic and societal upheaval worldwide

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call